Industry: Medical Devices & Consumables
Published Date: 2026-01-05
Pages: 116 Pages
Report ld: 5518744
Request Sample
Customized Report
MRI Contrast Agents Market Size(US$)

CAGR 2026-2032
5.9%
Market Size,2032
USD 2,463
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global MRI Contrast Agents market was valued at US$ 1661 million in 2025 and is anticipated to reach US$ 2463 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on MRI Contrast Agents competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
Global key MRI contrast agents core players include Bayer, Guerbet Group and Bracco Imaging etc. The top 3 companies hold a share about 82%. Asia-Pacific is the largest market with a share about 35%, followed by North America and Europe.
In terms of product, gadoterate meglumine product is the largest segment with a share about 27%. And in terms of applications, the largest application is hospital with a share about 84%.
This report delivers a comprehensive overview of the global MRI Contrast Agents market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding MRI Contrast Agents. The MRI Contrast Agents market size, estimates, and forecasts are provided in terms of sales volume (Liter) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global MRI Contrast Agents market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist MRI Contrast Agents manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for MRI Contrast Agents manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines MRI Contrast Agents sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 MRI Contrast Agents Market Overview
1.1 Product Definition
1.2 MRI Contrast Agents by Type
1.2.1 Global MRI Contrast Agents Market Value by Type: 2025 vs 2032
1.2.2 Gadobutrol
1.2.3 Gadoterate Meglumine
1.2.4 Gadobenate Dimeglumine
1.2.5 Gadopentetate Dimeglumine
1.2.6 Gadoteridol
1.2.7 Gadodiamine
1.2.8 Others
1.3 MRI Contrast Agents by Application
1.3.1 Global MRI Contrast Agents Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global MRI Contrast Agents Market Size Estimates and Forecasts
1.4.1 Global MRI Contrast Agents Revenue 2021–2032
1.4.2 Global MRI Contrast Agents Sales 2021–2032
1.4.3 Global MRI Contrast Agents Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 MRI Contrast Agents Market Competition by Manufacturers
2.1 Global MRI Contrast Agents Sales Market Share by Manufacturers (2021–2026)
2.2 Global MRI Contrast Agents Revenue Market Share by Manufacturers (2021–2026)
2.3 Global MRI Contrast Agents Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of MRI Contrast Agents, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of MRI Contrast Agents, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of MRI Contrast Agents, Product Types and Applications
2.7 Global Key Manufacturers of MRI Contrast Agents, Date of Entry into the Industry
2.8 Global MRI Contrast Agents Market Competitive Situation and Trends
2.8.1 Global MRI Contrast Agents Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global MRI Contrast Agents Players Market Share by Revenue
2.8.3 Global MRI Contrast Agents Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global MRI Contrast Agents Market Scenario by Region
3.1 Global MRI Contrast Agents Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global MRI Contrast Agents Sales by Region: 2021–2032
3.2.1 Global MRI Contrast Agents Sales by Region: 2021–2026
3.2.2 Global MRI Contrast Agents Sales by Region: 2027–2032
3.3 Global MRI Contrast Agents Revenue by Region: 2021–2032
3.3.1 Global MRI Contrast Agents Revenue by Region: 2021–2026
3.3.2 Global MRI Contrast Agents Revenue by Region: 2027–2032
3.4 North America MRI Contrast Agents Market Facts & Figures by Country
3.4.1 North America MRI Contrast Agents Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America MRI Contrast Agents Sales by Country (2021–2032)
3.4.3 North America MRI Contrast Agents Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe MRI Contrast Agents Market Facts & Figures by Country
3.5.1 Europe MRI Contrast Agents Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe MRI Contrast Agents Sales by Country (2021–2032)
3.5.3 Europe MRI Contrast Agents Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific MRI Contrast Agents Market Facts & Figures by Region
3.6.1 Asia Pacific MRI Contrast Agents Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific MRI Contrast Agents Sales by Region (2021–2032)
3.6.3 Asia Pacific MRI Contrast Agents Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America MRI Contrast Agents Market Facts & Figures by Country
3.7.1 Latin America MRI Contrast Agents Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America MRI Contrast Agents Sales by Country (2021–2032)
3.7.3 Latin America MRI Contrast Agents Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa MRI Contrast Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa MRI Contrast Agents Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa MRI Contrast Agents Sales by Country (2021–2032)
3.8.3 Middle East and Africa MRI Contrast Agents Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global MRI Contrast Agents Sales by Type (2021–2032)
4.1.1 Global MRI Contrast Agents Sales by Type (2021–2026)
4.1.2 Global MRI Contrast Agents Sales by Type (2027–2032)
4.1.3 Global MRI Contrast Agents Sales Market Share by Type (2021–2032)
4.2 Global MRI Contrast Agents Revenue by Type (2021–2032)
4.2.1 Global MRI Contrast Agents Revenue by Type (2021–2026)
4.2.2 Global MRI Contrast Agents Revenue by Type (2027–2032)
4.2.3 Global MRI Contrast Agents Revenue Market Share by Type (2021–2032)
4.3 Global MRI Contrast Agents Price by Type (2021–2032)
5 Segment by Application
5.1 Global MRI Contrast Agents Sales by Application (2021–2032)
5.1.1 Global MRI Contrast Agents Sales by Application (2021–2026)
5.1.2 Global MRI Contrast Agents Sales by Application (2027–2032)
5.1.3 Global MRI Contrast Agents Sales Market Share by Application (2021–2032)
5.2 Global MRI Contrast Agents Revenue by Application (2021–2032)
5.2.1 Global MRI Contrast Agents Revenue by Application (2021–2026)
5.2.2 Global MRI Contrast Agents Revenue by Application (2027–2032)
5.2.3 Global MRI Contrast Agents Revenue Market Share by Application (2021–2032)
5.3 Global MRI Contrast Agents Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer MRI Contrast Agents Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bayer MRI Contrast Agents Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Guerbet Group
6.2.1 Guerbet Group Company Information
6.2.2 Guerbet Group Description and Business Overview
6.2.3 Guerbet Group MRI Contrast Agents Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Guerbet Group MRI Contrast Agents Product Portfolio
6.2.5 Guerbet Group Recent Developments/Updates
6.3 Bracco Imaging
6.3.1 Bracco Imaging Company Information
6.3.2 Bracco Imaging Description and Business Overview
6.3.3 Bracco Imaging MRI Contrast Agents Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bracco Imaging MRI Contrast Agents Product Portfolio
6.3.5 Bracco Imaging Recent Developments/Updates
6.4 GE Healthcare
6.4.1 GE Healthcare Company Information
6.4.2 GE Healthcare Description and Business Overview
6.4.3 GE Healthcare MRI Contrast Agents Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 GE Healthcare MRI Contrast Agents Product Portfolio
6.4.5 GE Healthcare Recent Developments/Updates
6.5 BeiLu Pharma
6.5.1 BeiLu Pharma Company Information
6.5.2 BeiLu Pharma Description and Business Overview
6.5.3 BeiLu Pharma MRI Contrast Agents Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BeiLu Pharma MRI Contrast Agents Product Portfolio
6.5.5 BeiLu Pharma Recent Developments/Updates
6.6 Hengrui Medicine
6.6.1 Hengrui Medicine Company Information
6.6.2 Hengrui Medicine Description and Business Overview
6.6.3 Hengrui Medicine MRI Contrast Agents Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hengrui Medicine MRI Contrast Agents Product Portfolio
6.6.5 Hengrui Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 MRI Contrast Agents Industry Chain Analysis
7.2 MRI Contrast Agents Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 MRI Contrast Agents Production Mode & Process Analysis
7.4 MRI Contrast Agents Sales and Marketing
7.4.1 MRI Contrast Agents Sales Channels
7.4.2 MRI Contrast Agents Distributors
7.5 MRI Contrast Agents Customer Analysis
8 MRI Contrast Agents Market Dynamics
8.1 MRI Contrast Agents Industry Trends
8.2 MRI Contrast Agents Market Drivers
8.3 MRI Contrast Agents Market Challenges
8.4 MRI Contrast Agents Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global MRI Contrast Agents market size was US$ 1661 million in 2025 and is forecast to reach a readjusted size of US$ 2463 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 80
USD 4250.00
(Single User License)
The global market for MRI Contrast Agents was estimated to be worth US$ 1661 million in 2025 and is projected to reach US$ 2463 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 94
USD 3950.00
(Single User License)
The global MRI Contrast Agents market size was US$ 1578 million in 2024 and is forecast to a readjusted size of US$ 2339 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 77
USD 4250.00
(Single User License)
The global MRI Contrast Agents market is projected to grow from US$ 1578 million in 2024 to US$ 2339 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 145
USD 4900.00
(Single User License)
The global market for MRI Contrast Agents was estimated to be worth US$ 1578 million in 2024 and is forecast to a readjusted size of US$ 2339 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 91
USD 3950.00
(Single User License)
The global market for MRI Contrast Agents was valued at US$ 1578 million in the year 2024 and is projected to reach a revised size of US$ 2339 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-02-07
Pages: 80
USD 2900.00
(Single User License)
MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
Published Date: 2024-01-18
Pages: 100
USD 3950.00
(Single User License)
MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
Published Date: 2024-01-03
Pages: 84
USD 2900.00
(Single User License)
The global MRI Contrast Agents market size was US$ 1661 million in 2025 and is forecast to reach a readjusted size of US$ 2463 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 80
The global market for MRI Contrast Agents was estimated to be worth US$ 1661 million in 2025 and is projected to reach US$ 2463 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-01-05
Pages: 94
The global MRI Contrast Agents market size was US$ 1578 million in 2024 and is forecast to a readjusted size of US$ 2339 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 77
The global MRI Contrast Agents market is projected to grow from US$ 1578 million in 2024 to US$ 2339 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 145
The global market for MRI Contrast Agents was estimated to be worth US$ 1578 million in 2024 and is forecast to a readjusted size of US$ 2339 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 91
The global market for MRI Contrast Agents was valued at US$ 1578 million in the year 2024 and is projected to reach a revised size of US$ 2339 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-02-07
Pages: 80
MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
Published: 2024-01-18
Pages: 100
MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
Published: 2024-01-03
Pages: 84
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now